Our perifused pancreatic islet system can be used to determine whether potential antidiabetic agents alter insulin secretion from ß-cells in vitro. The islet assay established and validated by RenaSci can, therefore, be used as an invaluable tool in early screening for Type 2 diabetes drug discovery programmes.
Key features of the assay include:
Glucose-stimulated insulin secretion from
perifused pancreatic islets
GLP-1 increases glucose-stimulated insulin
secretion from perifused pancreatic islets
Get in touch to learn more about RenaSci’s in vitro pancreatic islet assay.
For more details or information on how we can support your project please complete the contact form.